TPA

(redirected from t-PA)
Also found in: Dictionary, Medical, Acronyms.
Related to t-PA: urokinase, heparin

TPA

(organic chemistry)

TPA

TPA

(Transient Program Area) See transient area.
References in periodicals archive ?
IA may be a treatment option for ALS when the occlusion is in a large artery, exclusion criteria for IV t-PA exist, and the patient is outside the window for IV t-PA treatment because IA fibrinolysis may be administered within 6 hours of symptom onset (Jauch et al.
PAI-1 polimorfizmi ve t-PA Alu repeat I/D polimorfizmi sikligi etnik gruplara ve cinsiyete gore de farklilik gostermektedir.
Our clinical experience indicates that especially t-PA is useful in the early period of thrombosis and if a response is to be obtained, the first two doses are responsed.
Table 1: Effect of scaling and root planning on t-PA [pretreatment ([T.
Further, the dissent concluded that the trial judge erred in refusing to admit into evidence the testimony of the Reeds' expert witnesses that the failure of the defendant hospital to have protocols in place for administering T-PA to stroke patients within the critical three-hour window was reversible error.
A recent report suggesting that women are less likely than men to receive IV thrombolytic therapy highlights the fact that a bias toward t-PA treatment in men may result in the unintended "targeting of treatment to patients who are actually less likely to benefit from therapy (i.
The fibrinolytic capacity of plasma is considered to be strongly dependent on the concentration of circulating t-PA, which is presumed to be derived mainly from the vascular wall, where it is localized in endothelial cells (ECs) (Emeis, 1988).
Specifically, acute intracranial hemorrhage and nonvascular causes of stroke symptoms need to be ruled out within 3 hours of symptom onset so that the use of IV t-PA can be considered.
It is constructed with amino acid substitutions at three sites (the letters T, N and K represent the three regions changed from the natural t-PA protein).
The only treatment for strokes now approved in the United States is the drug t-PA, which is given intravenously and acts something like Drano to dissolve a clot.
A: T-PA is a clot bluster, and it is useful in thrombotic stroke if given early enough.
Similarly, in a cost-effective analysis of thrombolytic therapy with tissue plasminogen activator (t-PA) compared to streptokinase, the authors conclude, "The cost-effectiveness of treatment with accelerated t-PA rather than streptokinase compares favorably with that of other therapies whose added medical benefit for dollars spent is judged by society to be worthwhile.